# Alpha-0261 Tablets for Moderate-to-Severe Ulcerative Colitis

> **NCT07744646** · PHASE1 · NOT_YET_RECRUITING · sponsor: **The First Affiliated Hospital of Anhui Medical University** · enrollment: 10 (estimated)

## Conditions studied

- Ulcerative Colitis (UC)

## Interventions

- **DRUG:** Alpha-0261

## Key facts

- **NCT ID:** NCT07744646
- **Lead sponsor:** The First Affiliated Hospital of Anhui Medical University
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-08-03
- **Primary completion:** 2027-01-09
- **Final completion:** 2027-03-20
- **Target enrollment:** 10 (ESTIMATED)
- **Last updated:** 2026-08-04

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07744646

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07744646, "Alpha-0261 Tablets for Moderate-to-Severe Ulcerative Colitis". Retrieved via MORVS 2026-10-20 from https://api.morvs.ai/clinical/NCT07744646. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*